drugset / Trial / NCT00026637

Depression and Health Outcomes in Refractory Epilepsy

NCT00026637

RandomizedParallel-groupOpen-labelTreatment

Summary

To define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in persons with depression and refractory epilepsy.

Timeline

Start
2001-08
Primary completion
2007-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule Oral